<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bekhterev</journal-id><journal-title-group><journal-title xml:lang="ru">Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева</journal-title><trans-title-group xml:lang="en"><trans-title>V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7053</issn><issn pub-type="epub">2713-055X</issn><publisher><publisher-name>V. M. BEKHTEREV  NATIONAL  RESEARCH  MEDICAL  CENTER  FOR  PSYCHIATRY  AND  NEUROLOGY                           OF    THE  RUSSIAN  FEDERATION   MINISTRY  OF  HEALTH</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31363/2313-7053-2026-2-1327</article-id><article-id custom-type="elpub" pub-id-type="custom">bekhterev-1386</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>В ПОМОЩЬ ПРАКТИКУЮЩЕМУ ВРАЧУ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>GUIDELINES FOR THE PRACTITIONER</subject></subj-group></article-categories><title-group><article-title>Клинический случай применения карипразина у пациента с биполярным аффективным расстройством и низкой приверженностью к терапии</article-title><trans-title-group xml:lang="en"><trans-title>Case Report: Cariprazine Use in the Management of Bipolar Disorder with Non-compliance</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2148-297X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Счастный</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Schastnyy</surname><given-names>E. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Счастный Евгений Дмитриевич — доктор медицинских наук, профессор, руководитель отделения аффективных состояний</p></bio><bio xml:lang="en"><p>Evgeny D. Schastnyy</p></bio><email xlink:type="simple">evgeny.schastnyy@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5112-2188</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Украинцев</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ukraintsev</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Украинцев Игорь Иванович — кандидат медицинских наук , ассистент кафедры психиатрии, наркологии и психотерапии</p></bio><bio xml:lang="en"><p>Igor I. Ukraintsev</p></bio><email xlink:type="simple">garic58garic@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт психического здоровья, Томский национальный исследовательский медицинский центр Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Сибирский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>28</day><month>05</month><year>2026</year></pub-date><volume>60</volume><issue>2</issue><fpage>109</fpage><lpage>113</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Счастный Е.Д., Украинцев И.И., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Счастный Е.Д., Украинцев И.И.</copyright-holder><copyright-holder xml:lang="en">Schastnyy E.D., Ukraintsev I.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bekhterevreview.com/jour/article/view/1386">https://www.bekhterevreview.com/jour/article/view/1386</self-uri><abstract><p>Представлен сложный для реабилитации клинический случай пациентки с биполярным аффективным расстройством (БАР). В описанном случае подробно описано начало заболевания, дальнейшая его динамика, персонифицированный подбор терапии с последующим назначением карипразина, на фоне которого повысилась комплаентность пациентки. Интерес представленного случая для профессионального рассмотрения и обсуждения обусловлен доказанной практическим путем эффективностью применению карипразина при низкой степени соблюдения пациентом врачебных рекомендаций, а именно побочные эффекты препаратов и сложные схемы профилактического лечения.</p></abstract><trans-abstract xml:lang="en"><p>This article presents a challenging rehabilitation case of a female patient with bipolar disorder (BD). The described case details the onset of the disease, its subsequent progression, and personalized therapy selection, culminating in the prescription of cariprazine, which improved the patient’s compliance. The significance of this case for professional discussion lies in the empirically demonstrated efficacy of cariprazine in patients with low adherence to medical recommendations, particularly due to side effects of medications and complex prophylactic treatment regimens.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>карипразин</kwd><kwd>биполярное аффективное расстройство</kwd><kwd>отсутствие комплаентности</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cariprazine</kwd><kwd>bipolar disorder</kwd><kwd>non-compliance</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование осуществлено в соответствии с бюджетным финансированием госзадания НИИ психического здоровья № 075-00491-26-00 в рамках комплексной темы НИР «Персонализированная терапия больных расстройствами шизофренического и аффективного спектра на основе клинически верифицированных констелляций маркеров их морфологического, биохимического и когнитивного фенотипов» (номер госрегистрации 126022417834-4. Протокол ЛЭКа № 189/3.2025 от 9 декабря 2025 года.</funding-statement><funding-statement xml:lang="en">The study was carried out in accordance with the budgetary financing of the state assignment of the Mental Health Research Institute No. 075-00491-26-00 as part of the complex research topic «Personalized Therapy for Patients with Schizophrenic and Affective Spectrum Disorders Based on Clinically Verified Constellations of Markers of Their Morphological, Biochemical, and Cognitive Phenotypes» (registration number 126022417834-4. Protocol of the LEC No. 189/3.2025 dated December 9, 2025.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Кибитов АО, Шумская ДС, Пинахина ДВ. и др. Специфические метаболические и воспали тельные профили пациентов с гипергликемией при биполярном аффективном расстройстве, рекуррентной депрессии и шизофрении: результаты трансдиагностического исследования. Сибирский вестник психиатрии и наркологии. 2025;4(129): 43-56.</mixed-citation><mixed-citation xml:lang="en">Kibitov AO, Shumskaia DS, Pinakhina DV. et al. Specific metabolic and inflammatory profiles of patients with hyperglycemia in bipolar affective disorder, recurrent depression and schizophrenia: results of a transdiagnostic study. Siberian Herald of Psychiatry and Addiction Psychiatry. 2025; 4 (129): 43-56. https://doi.org/10.26617/1810-3111-2025-4(129)-43-56</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Arvilommi P, Pallaskorpi S, Linnaranta O, et al. Long-term work disability due to type I and II bipolar disorder: findings of a six-year prospective study. Int J Bipolar Disord. 2022;10(1):19. https://doi.org/10.1186/s40345-022-00264-6</mixed-citation><mixed-citation xml:lang="en">Arvilommi P, Pallaskorpi S, Linnaranta O, et al. Long-term work disability due to type I and II bipolar disorder: findings of a six-year prospective study. Int J Bipolar Disord. 2022;10(1):19. https://doi.org/10.1186/s40345-022-00264-6</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Fountoulakis KN, Ioannou M, Tohen M, et al. Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data. Eur Neuropsychopharmacol. 2023;72:30–39. https://doi.org/10.1016/j.euroneuro.2023.03.009</mixed-citation><mixed-citation xml:lang="en">Fountoulakis KN, Ioannou M, Tohen M, et al. Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data. Eur Neuropsychopharmacol. 2023;72:30–39. https://doi.org/10.1016/j.euroneuro.2023.03.009</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Grande I, Goikolea M, de Dios C, et al. Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data). Acta Psychiatr Scand. 2013;127 (5):403-411. https://doi.org/10.1111/acps.12003</mixed-citation><mixed-citation xml:lang="en">Grande I, Goikolea M, de Dios C, et al. Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data). Acta Psychiatr Scand. 2013;127 (5):403-411. https://doi.org/10.1111/acps.12003</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hong J, Reed C, Novick D, et al. Clinical and economic consequences of medication non adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European mania in bipolar longitudinal evaluation of medication (EMBLEM) study. Psychiatry Res. 2011;190:110–114. https://doi.org/10.1016/j.psychres.2011.04.016</mixed-citation><mixed-citation xml:lang="en">Hong J, Reed C, Novick D, et al. Clinical and economic consequences of medication non adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European mania in bipolar longitudinal evaluation of medication (EMBLEM) study. Psychiatry Res. 2011;190:110–114. https://doi.org/10.1016/j.psychres.2011.04.016</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Li K, Liao Y, Yang Z, et al. Case Report: Paliperidone Palmitate in the Management of Bipolar I Disorder With Non-complianceFront Psychiatry. 2021;111:529672. https://doi.org/10.3389/fpsyt.2020.529672</mixed-citation><mixed-citation xml:lang="en">Li K, Liao Y, Yang Z, et al. Case Report: Paliperidone Palmitate in the Management of Bipolar I Disorder With Non-complianceFront Psychiatry. 2021;111:529672. https://doi.org/10.3389/fpsyt.2020.529672</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mazza M, Marano G, Traversi G, et al. Cariprazine in bipolar depression and mania: State of the art. CNS Neurol Disord Drug Targets. 2018;17(10):723–727. https://doi.org/10.2174/1871527317666180828120-256</mixed-citation><mixed-citation xml:lang="en">Mazza M, Marano G, Traversi G, et al. Cariprazine in bipolar depression and mania: State of the art. CNS Neurol Disord Drug Targets. 2018;17(10):723–727. https://doi.org/10.2174/1871527317666180828120-256</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241-251. https://doi.org/10.1001/archgenpsychiatry.2011.12</mixed-citation><mixed-citation xml:lang="en">Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241-251. https://doi.org/10.1001/archgenpsychiatry.2011.12</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pezzin LE, Larson ER, Lorber W, et al. Music instruction intervention for treatment of posttraumatic stress disorder: a randomized pilot study. BMC Psychol. 2018;6:60. https://doi.org/10.1186/s40359-018-0274-8</mixed-citation><mixed-citation xml:lang="en">Pezzin LE, Larson ER, Lorber W, et al. Music instruction intervention for treatment of posttraumatic stress disorder: a randomized pilot study. BMC Psychol. 2018;6:60. https://doi.org/10.1186/s40359-018-0274-8</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Rybakowski JK. Mood stabilizers of first and second generation. Brain Sci. 2023;13(5):741. https://doi.org/10.3390/brainsci13050741</mixed-citation><mixed-citation xml:lang="en">Rybakowski JK. Mood stabilizers of first and second generation. Brain Sci. 2023;13(5):741. https://doi.org/10.3390/brainsci13050741</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Schaffer A., Isometsa E.T., Tondo L. et al. Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: part I of a report of the International society for bipolar disorders task force on suicide in bipolar disorder // Aust N Z J Psychiatry. — 2015. — No 49. — P. 785–802. https://doi.org/10.1177/0004867415594427</mixed-citation><mixed-citation xml:lang="en">Schaffer A., Isometsa E.T., Tondo L. et al. Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: part I of a report of the International society for bipolar disorders task force on suicide in bipolar disorder // Aust N Z J Psychiatry. — 2015. — No 49. — P. 785–802. https://doi.org/10.1177/0004867415594427</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Torres-Llenza V, Lakshmin P, Lieberman DZ. Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients. Neuropsychiatr Dis Treat. 2018;14:285–292. https://doi.org/10.2147/NDT.S129559</mixed-citation><mixed-citation xml:lang="en">Torres-Llenza V, Lakshmin P, Lieberman DZ. Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients. Neuropsychiatr Dis Treat. 2018;14:285–292. https://doi.org/10.2147/NDT.S129559</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
